From the publishers of JADPRO
Metastatic HER2-Positive Breast Cancer
Resource Center
Menu
Resources
Videos
Videos
Quizzes
News & Literature Highlights
Case Studies
Advertisement
Interview With Kristina Byers, PharmD, BCOP: Trastuzumab Deruxtecan in the Treatment of HER2+ Breast Cancer
Last Updated: Friday, July 17, 2026
Advertisement
Case Studies
De Novo Oligometastatic HER2+ Breast Cancer
Second-Line Trastuzumab Deruxtecan Treatment and Side-Effect Management
ER+/PR+ HER2+ Breast Cancer With Brain Metastases
Advertisement
Quizzes
Test your knowledge of ERBB2 mutation in HER2 non-amplified breast cancer
Test your knowledge on de novo oligometastatic metastatic HER2+ breast cancer
Test your knowledge on second-line treatment and side-effect management in mHER2+ breast cancer